Budget Impact Analysis of the Introduction of Saxagliptin/Metformin Extended-Release (Xr) in the Treatment of Type-2 Diabetes in Chile

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.796
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

PDB2 Systematic Literature Review of the Efficacy and Safety of Metformin Extended Release Relative to Metformin Immediate Release in the Treatment of Type 2 Diabetes Mellitus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Pdb38 - Budget Impact Analysis of Benaglutide Injection in the Treatment of Type 2 Diabetes in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Compliance and Efficacy of Extended Release Metformin and Immediate Release Thrice Daily Metformin in Type-2 Diabetes Mellitus- A Comparative Study

IOSR Journal of Dental and Medical Sciences
2014English

Profile of Saxagliptin in the Treatment of Type 2 Diabetes: Focus on Japanese Patients

Therapeutics and Clinical Risk Management
2014English

Budget Impact Analysis of Adding Dapaglifozin to the Therapy of Diabetes Mellitus Type 2 in Bulgaria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Use of Metformin and Vildagliptin for Treatment of Type 2 Diabetes in the Elderly

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Metformin Remains the Best Treatment for Type 2 Diabetes

BMJ
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy